AG真人官方

Malone Wealth Ventures LLC, a U.S. registered investment adviser, filed Schedule 13G/A (Amendment No. 5) on 10 July 2025 disclosing a significant position in Quantum Biopharma Ltd. (QNTM). The firm reports beneficial ownership of 735,148 Class B subordinate voting shares, equating to 19.4 % of the outstanding class. Malone retains sole voting power over 103,601 shares and sole dispositive power over the full stake; no shares are subject to shared voting or dispositive power. The difference indicates that most shares are held for advisory clients who keep voting rights while Malone manages disposition.

The filer certifies the shares were acquired in the ordinary course of business and not to influence control. No subsidiaries or group members are involved, and no single client holds more than 5 % of the class. Quantum Biopharma鈥檚 headquarters remain at 55 University Ave., Suite 1003, Toronto, Ontario.

This near-20 % holding positions Malone as a major stakeholder, improving institutional visibility for Quantum Biopharma and potentially stabilising the shareholder base. Investors should monitor upcoming ownership updates, as any move above the 20 % threshold or a switch to Schedule 13D could signal a change in strategic intent.

Malone Wealth Ventures LLC filed Amendment No. 4 to Schedule 13G on 10 July 2025, reporting a sizeable passive stake in Quantum Biopharma Ltd. (QNTM).

• Ownership level: The filing discloses beneficial ownership of approximately 19鈥�20 % of QNTM鈥檚 common shares, equating to 689,421鈥�735,148 shares depending on the section cited.
• Voting vs. dispositive power: Malone holds sole voting power over 103,601鈥�109,765 shares but sole dispositive power over the full reported amount; no shared powers are reported.
• Filing status: The adviser filed on a Schedule 13G, indicating the position is held in the ordinary course of business and not with the intent to influence control of the issuer.
• Entity details: Malone Wealth Ventures LLC is a U.S.-based registered investment adviser; its clients ultimately benefit from dividends or sale proceeds, and no single client exceeds the 5 % threshold.
• Signatory: Kevin M. Malone, President & CEO, signed the certification.

The filing confirms that a professional asset manager has accumulated a near-20 % stake, potentially lending market confidence and increasing the free-float concentration, while remaining a passive investor. Investors should note the internal inconsistency between share counts (689,421 vs 735,148) and the consequent slight difference in reported ownership percentage (19.9 % vs 19.4 %).